Most Cited Papers In Last Two Years

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Issue on combined locoregional and systemic treatment for hepatocellular carcinoma

Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers' perspectives

Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression

Challenges and barriers in hepatocellular carcinoma (HCC) surveillance for patients with non-alcoholic fatty liver disease (NAFLD)

Is the Mediterranean diet a good preventive measure for NASH?

Current landscape and future directions for systemic treatments of hepatocellular carcinoma

Expression and function of collagens in intrahepatic cholangiocarcinoma

Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States

Imaging after liver-directed therapy: evidenced-based update of the LI-RADS treatment response algorithm

Chemoembolization with Degradable Starch Microspheres (DSM-TACE): expanding indications in HCC multidisciplinary tumor board

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

The role of tumor microenvironment in cholangiocarcinoma

Targeting the interactions between lymphocytes and liver cancer stem cells in combination with immunotherapy is a promising therapeutic strategy

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles

MASLD: an emerging factor in the pathophysiology and clinical management of ICC